Royalty Pharma
RPRX
$31.56
Share price
-6.52%
Change (1 day)
4.23%
Change (1 year)
Categories
Royalty Pharma (RPRX) Fails to deliver data
Key failure to deliver metrics for Royalty Pharma:
- Last SEC data release: 2025-02-28
- Last 15 days FTD volume: $12.32 M
- Last 3 months FTD volume: $33.94 M
- Last year FTD volume: $33.94 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Royalty Pharma (RPRX) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Royalty Pharma (RPRX) - since 2020
Volume in USD (price x number of shares), data since 2020Royalty Pharma (RPRX) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | $16.41 M | -41.54% |
| 2024 | $28.08 M | 45.75% |
| 2023 | $19.26 M | -64.47% |
| 2022 | $54.22 M | -15.8% |
| 2021 | $64.39 M | 67.97% |
| 2020 | $38.33 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | $2.3 M | $4.43 M | 🇺🇸 USA |
 | $0.23 B | $0.29 B | 🇺🇸 USA |
 | $67.4 M | $0.23 B | 🇺🇸 USA |